NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $2,180,000 | +116.5% | 825,810 | -3.3% | 0.00% | – |
Q4 2019 | $1,007,000 | -35.3% | 854,119 | -5.5% | 0.00% | – |
Q3 2019 | $1,556,000 | -57.1% | 904,190 | +18.1% | 0.00% | – |
Q2 2019 | $3,631,000 | -18.1% | 765,850 | +11.6% | 0.00% | – |
Q1 2019 | $4,433,000 | +186.4% | 686,121 | +122.9% | 0.00% | – |
Q4 2018 | $1,548,000 | -34.1% | 307,782 | +12.0% | 0.00% | – |
Q3 2018 | $2,348,000 | – | 274,839 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 9,741,636 | $16,756,000 | 9.49% |
MYDA Advisors LLC | 155,000 | $267,000 | 0.12% |
Endurant Capital Management LP | 193,052 | $332,000 | 0.12% |
FNY Investment Advisers, LLC | 210,000 | $361,000 | 0.11% |
HARVARD MANAGEMENT CO INC | 505,871 | $870,000 | 0.08% |
Alambic Investment Management, L.P. | 25,800 | $44,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 209,307 | $360,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 155,619 | $268,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 116,600 | $201,000 | 0.00% |
Tower Research Capital LLC (TRC) | 14,371 | $25,000 | 0.00% |